C A Wallace

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. pmc Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology
    Norman T Ilowite
    Children s Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY, USA
    Pediatr Rheumatol Online J 10:31. 2012
  2. pmc Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis
    Carol A Wallace
    Seattle Children s Hospital, Seattle, WA, USA
    Arthritis Rheum 64:2012-21. 2012
  3. pmc Summary of worldwide pediatric malignancies reported after exposure to etanercept
    Peter McCroskery
    Amgen Inc, Thousand Oaks, CA, Seattle WA, and South San Francisco, CA, USA
    Pediatr Rheumatol Online J 8:18. 2010
  4. pmc Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis
    Kristen Hayward
    Division of Rheumatology, University of Washington School of Medicine, Seattle Children s Hospital, 4800 Sandpoint Way, NE MS R 5420, Seattle, WA 98105, USA
    Arthritis Res Ther 11:216. 2009
  5. ncbi request reprint Current management of juvenile idiopathic arthritis
    Carol A Wallace
    Division of Immunology, Rheumatology and Infectious Diseases, Children s Hospital and Regional Medical Center, University of Washington School of Medicine, 4800 Sandpoint Way NE MS B 6583, Seattle, WA 98105, USA
    Best Pract Res Clin Rheumatol 20:279-300. 2006
  6. ncbi request reprint Preliminary validation of clinical remission criteria using the OMERACT filter for select categories of juvenile idiopathic arthritis
    Carol A Wallace
    Division of Immunology, Rheumatology, and Infectious Disease, Children s Hospital and Regional Medical Center, Seattle, Washington 98105, USA
    J Rheumatol 33:789-95. 2006
  7. ncbi request reprint Patterns of clinical remission in select categories of juvenile idiopathic arthritis
    Carol A Wallace
    Children s Hospital and Regional Medical Center, and University of Washington School of Medicine, 4800 Sand Point Way NE, Seattle, WA 98105, USA
    Arthritis Rheum 52:3554-62. 2005
  8. ncbi request reprint Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis
    Carol A Wallace
    Children s Hospital and Regional Medical Center, Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington 98105, USA
    J Rheumatol 31:2290-4. 2004
  9. doi request reprint American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis
    Carol A Wallace
    Seattle Children s Hospital and University of Washington School of Medicine, Seattle
    Arthritis Care Res (Hoboken) 63:929-36. 2011
  10. ncbi request reprint Initial intravenous gammaglobulin treatment failure in Kawasaki disease
    C A Wallace
    Department of Pediatrics, University of Washington and Children s Hospital and Regional Medical Center, Seattle, Washington 98105 0371, USA
    Pediatrics 105:E78. 2000

Collaborators

Detail Information

Publications23

  1. pmc Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology
    Norman T Ilowite
    Children s Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY, USA
    Pediatr Rheumatol Online J 10:31. 2012
    ..abstract:..
  2. pmc Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis
    Carol A Wallace
    Seattle Children s Hospital, Seattle, WA, USA
    Arthritis Rheum 64:2012-21. 2012
    ..To determine whether aggressive treatment initiated early in the course of rheumatoid factor (RF)-positive or RF-negative polyarticular juvenile idiopathic arthritis (JIA) can induce clinical inactive disease within 6 months...
  3. pmc Summary of worldwide pediatric malignancies reported after exposure to etanercept
    Peter McCroskery
    Amgen Inc, Thousand Oaks, CA, Seattle WA, and South San Francisco, CA, USA
    Pediatr Rheumatol Online J 8:18. 2010
    ..We examined the worldwide experience of etanercept use in pediatric patients and the occurrence of malignancies as reported from clinical trials, registry studies, post-marketing surveillance, and published scientific literature...
  4. pmc Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis
    Kristen Hayward
    Division of Rheumatology, University of Washington School of Medicine, Seattle Children s Hospital, 4800 Sandpoint Way, NE MS R 5420, Seattle, WA 98105, USA
    Arthritis Res Ther 11:216. 2009
    ..The present article will summarize recent developments in the medical treatment of children with JIA and will offer insights into emerging therapies...
  5. ncbi request reprint Current management of juvenile idiopathic arthritis
    Carol A Wallace
    Division of Immunology, Rheumatology and Infectious Diseases, Children s Hospital and Regional Medical Center, University of Washington School of Medicine, 4800 Sandpoint Way NE MS B 6583, Seattle, WA 98105, USA
    Best Pract Res Clin Rheumatol 20:279-300. 2006
    ..This chapter will discuss the current approaches to medical management of JIA and the medications currently available for use. JIA treatment is a vast, rich area in need of research...
  6. ncbi request reprint Preliminary validation of clinical remission criteria using the OMERACT filter for select categories of juvenile idiopathic arthritis
    Carol A Wallace
    Division of Immunology, Rheumatology, and Infectious Disease, Children s Hospital and Regional Medical Center, Seattle, Washington 98105, USA
    J Rheumatol 33:789-95. 2006
    ..To begin the validation process of the preliminary criteria for inactive disease (ID), clinical remission on medication (CRM), and clinical remission off medication (CR) in children with select forms of juvenile idiopathic arthritis (JIA)...
  7. ncbi request reprint Patterns of clinical remission in select categories of juvenile idiopathic arthritis
    Carol A Wallace
    Children s Hospital and Regional Medical Center, and University of Washington School of Medicine, 4800 Sand Point Way NE, Seattle, WA 98105, USA
    Arthritis Rheum 52:3554-62. 2005
    ....
  8. ncbi request reprint Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis
    Carol A Wallace
    Children s Hospital and Regional Medical Center, Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington 98105, USA
    J Rheumatol 31:2290-4. 2004
    ..To develop preliminary criteria for inactive disease and clinical remission for select categories of juvenile idiopathic arthritis (JIA), and to decide what such clinical states should predict in terms of probability of disease recurrence...
  9. doi request reprint American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis
    Carol A Wallace
    Seattle Children s Hospital and University of Washington School of Medicine, Seattle
    Arthritis Care Res (Hoboken) 63:929-36. 2011
    ..To prospectively validate the preliminary criteria for clinical inactive disease (CID) in patients with select categories of juvenile idiopathic arthritis (JIA)...
  10. ncbi request reprint Initial intravenous gammaglobulin treatment failure in Kawasaki disease
    C A Wallace
    Department of Pediatrics, University of Washington and Children s Hospital and Regional Medical Center, Seattle, Washington 98105 0371, USA
    Pediatrics 105:E78. 2000
    ....
  11. ncbi request reprint Short- and long-term outcomes of children with complex regional pain syndrome type I treated with exercise therapy
    D D Sherry
    Department of Pediatrics, University of Washington, Children s Hospital and Medical Center, Seattle 98105, USA
    Clin J Pain 15:218-23. 1999
    ..To report the initial and long-term outcome after an intensive exercise therapy program for childhood complex regional pain syndrome, type I (CRPS)...
  12. ncbi request reprint Measuring clinical response and remission in juvenile idiopathic arthritis
    Sarah Ringold
    Department of Rheumatology, Children s Hospital and Regional Medical Center University of Washington, Seattle, Washington, USA
    Curr Opin Rheumatol 19:471-6. 2007
    ....
  13. ncbi request reprint Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial
    Daniel J Lovell
    Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio 45229 3039, USA
    Arthritis Rheum 48:218-26. 2003
    ..All patients had been participants in an initial randomized efficacy and safety trial of etanercept...
  14. ncbi request reprint Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies
    Adam M Huber
    IWK Health Centre and Dalhousie University, 5850 University Avenue, Halifax, Nova Scotia B3J 3G9, Canada
    Arthritis Rheum 50:1595-603. 2004
    ....
  15. ncbi request reprint Normal scores for nine maneuvers of the Childhood Myositis Assessment Scale
    Robert M Rennebohm
    Division of Pediatric Rheumatolgy, Columbus Children s Hospital and The Ohio State University, 43205, USA
    Arthritis Rheum 51:365-70. 2004
    ..To document and evaluate the scores that normal, healthy children achieve when performing 9 maneuvers of the Childhood Myositis Assessment Scale (CMAS)...
  16. ncbi request reprint Old challenges and new directions in pediatric rheumatology
    David A Cabral
    Department of Rheumatology, Division of Pediatrics, B C Children s Hospital, University of British Columbia UBC, Vancouver, BC, Canada
    J Rheumatol 33:173-84. 2006
    ..Speakers were past and present fellows, local basic science and adult rheumatology colleagues, and pediatric rheumatologists from the Pacific North West...
  17. doi request reprint Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial
    Nicolino Ruperto
    IRCCS G Gaslini, PRINTO, Genoa, Italy
    Lancet 372:383-91. 2008
    ..We aimed to assess the safety and efficacy of abatacept, a selective T-cell costimulation modulator, in children with juvenile idiopathic arthritis who had failed previous treatments...
  18. doi request reprint Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
    Daniel J Lovell
    Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio 45229, USA
    Arthritis Rheum 58:1496-504. 2008
    ..To evaluate the safety and efficacy of up to 8 years of etanercept treatment in patients with polyarticular-course juvenile rheumatoid arthritis (JRA)...
  19. pmc Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity
    April Bingham
    From Office of Clinical Research, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, Maryland 20892 1301, USA
    Medicine (Baltimore) 87:70-86. 2008
    ..Further study is warranted to investigate the pathogenesis of acquired LD in patients with DM...
  20. pmc Alternative scoring of the Cutaneous Assessment Tool in juvenile dermatomyositis: results using abbreviated formats
    Adam M Huber
    Izaak Walton Killam Health Centre and Dalhousie University, Halifax, Nova Scotia, Canada
    Arthritis Rheum 59:352-6. 2008
    ..The goal of this study was to determine whether alternative scoring methods would shorten the CAT without compromising its measurement characteristics...
  21. doi request reprint Preliminary validation and clinical meaning of the Cutaneous Assessment Tool in juvenile dermatomyositis
    Adam M Huber
    Division of Pediatric Rheumatology, IWK Health Centre and Dalhousie University, Halifax, Nova Scotia, Canada
    Arthritis Rheum 59:214-21. 2008
    ..To provide preliminary validation of the Cutaneous Assessment Tool (CAT), a new tool to assess cutaneous manifestations of juvenile dermatomyositis (DM), and to explore the clinical meaning of CAT scores...
  22. ncbi request reprint Polysomnography and self-reported sleep, pain, fatigue, and anxiety in children with active and inactive juvenile rheumatoid arthritis
    Teresa M Ward
    Biobehavioral Nursing and Health Systems, University of Washington, Seattle, WA, 98195 7266, USA
    J Pediatr Psychol 33:232-41. 2008
    ..To compare polysomnography (PSG) and self-reported sleep, symptoms (pain and fatigue), and anxiety between children with active and inactive juvenile rheumatoid arthritis (JRA) and examine relations among sleep, symptoms, and anxiety...
  23. ncbi request reprint Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis
    Daniel J Lovell
    Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio 45229, USA
    Arthritis Rheum 54:1987-94. 2006
    ..The goal of our study was to provide data on safety and efficacy after 4 years of etanercept treatment in patients with JRA...